When Big Data and Plant-Based Medical Treatments Collide
Connect with us

When Big Data and Plant-Based Medical Treatments Collide

The following content is sponsored by RYAH MedTech


Ryah

When Big Data and Plant-Based Medical Treatments Collide

Plant-based medical treatments are gaining popularity, as consumers become increasingly more privy to their various health benefits.

By 2030, the global botanical and plant-derived drug market is expected to reach $37.8 billion, at a compound annual growth rate (CAGR) of 3.5%.

Yet, while its future looks promising, the industry still some roadblocks to overcome. This graphic by RYAH MedTech looks at the key issues the plant-based medical industry is facing, and how big data can help solve them.

Key Industry Roadblocks

Plant-based treatments—such as medical cannabis—have come a long way in recent years. However, inconsistencies in regulation and dosage are making it hard for the industry to reach its full potential.

  • Inconsistent regulation
    Access to medical cannabis is still not equal across America, but legalization is becoming increasingly more widespread. For instance, Kansas passed a bill earlier this year that will legalize medical cannabis, as soon as the legislation is passed through the Senate.
  • Inconsistent dosage standards
    While consumers have expressed a desire for standardized dosing, there is no current jurisdiction to guide consumption. For example, studies have shown a lack of genetic consistency among different products that claim to use the same strain.
  • Knowledge gap
    Many physicians see the value in plant-based treatments, but some still don’t feel comfortable talking to patients about it. A recent survey found that 50% of Michigan-based healthcare respondents—where medical cannabis has been legal since 2008—didn’t feel comfortable answering patient questions about medical cannabis.

In order to overcome these challenges, the industry needs to fill the knowledge gap and ultimately boost credibility.

For this to happen, plant-based treatments need to become more predictable and standardized. And that’s where big data and analytics can help.

Big Data’s Big Role in the Industry

Big data refers to large datasets that continually grow. These datasets are made up of information that is sourced from things like apps, devices, and online platforms. The need to leverage data in the plant-based medicine industry has resulted in an explosion of innovation.

RYAH MedTech collects massive amounts of patient data through devices such as smart inhalers, pens, and patches. These devices track, synthesize, and analyze patient information, which can help create a more personalized treatment plan tailored to the patient and their specific needs.

In addition to helping boost the patient’s experience, big data also has the potential to fill the knowledge gap within the plant-based medical industry and give physicians the information they need, which could boost its overall credibility.

Data is the Answer

Plant-based medical treatments have vast potential—so much so, that adjacent industries are taking measures to protect their market share.

But the industry needs to become more standardized before it can level up. This is why companies like RYAH MedTech are helping to close the gap in missing data, through a suite of IoT devices and software.

Subscribe to Visual Capitalist
Click for Comments

You may also like

Subscribe